Europe Point-Of-Care Molecular Diagnostics Market Size, Share & Trends Report

Europe Point-Of-Care Molecular Diagnostics Market (2025 - 2030) Size, Share & Trends Analysis Report By Application (Infectious Disease, Oncology), By Test Location, By Technology (PCR Based, Genetic Sequencing Based), By End Use, By Country, And Segment Forecasts

Market Segmentation

Europe Point-Of-Care Molecular Diagnostics Application Outlook (Revenue, USD Million, 2018 - 2030)
- Infectious Diseases
  - HIV POC
  - Clostridium difficile POC
  - HBV POC
  - Pneumonia or Streptococcus associated infections
  - Respiratory syncytial virus (RSV) POC
  - HPV POC
  - Influenza/Flu POC
  - HCV POC
  - MRSA POC
  - TB and drug-resistant TB POC
  - HSV POC
  - Other Infectious Diseases
- Oncology
- Hematology
  - Complete blood count (CBC)
  - Prothrombin time (PT)
  - Partial Thromboplastin Time (PTT)
  - Others
- Prenatal Testing
- Endocrinology
- Other Applications
Europe Point-Of-Care Molecular Diagnostics Test Location Outlook (Revenue, USD Million, 2018 - 2030)
- POC
- OTC
Europe Point-Of-Care Molecular Diagnostics Technology Outlook (Revenue, USD Million, 2018 - 2030)
- PCR-based
- Genetic Sequencing-based
- Hybridization-based
- Microarray-based
Europe Point-Of-Care Molecular Diagnostics End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Other uses
Europe Point-Of-Care Molecular Diagnostics Country Outlook (Revenue, USD Million, 2018 - 2030)
- UK
  - UK Point-Of-Care Molecular Diagnostics, by Application
    - Infectious Diseases
      - HIV POC
      - Clostridium difficile POC
      - HBV POC
      - Pneumonia or Streptococcus associated infections
      - Respiratory syncytial virus (RSV) POC
      - HPV POC
      - Influenza/Flu POC
      - HCV POC
      - MRSA POC
      - TB and drug-resistant TB POC
      - HSV POC
      - Other Infectious Diseases
    - Oncology
    - Hematology
      - Complete blood count (CBC)
      - Prothrombin time (PT)
      - Partial Thromboplastin Time (PTT)
      - Others
    - Prenatal Testing
    - Endocrinology
    - Other Applications
  - UK Point-Of-Care Molecular Diagnostics, by Test
    - OTC
    - POC
  - UK Point-Of-Care Molecular Diagnostics, by Technology
    - PCR-based
    - Genetic Sequencing-based
    - Hybridization-based
    - Microarray-based
  - UK Point-Of-Care Molecular Diagnostics, by End Use
    - Decentralized Labs
    - Hospitals
    - Home-care
    - Assisted Living Healthcare Facilities
    - Other uses
- Germany
  - Germany Point-Of-Care Molecular Diagnostics, by Application
    - Infectious Diseases
      - HIV POC
      - Clostridium difficile POC
      - HBV POC
      - Pneumonia or Streptococcus associated infections
      - Respiratory syncytial virus (RSV) POC
      - HPV POC
      - Influenza/Flu POC
      - HCV POC
      - MRSA POC
      - TB and drug-resistant TB POC
      - HSV POC
      - Other Infectious Diseases
    - Oncology
    - Hematology
      - Complete blood count (CBC)
      - Prothrombin time (PT)
      - Partial Thromboplastin Time (PTT)
      - Others
    - Prenatal Testing
    - Endocrinology
    - Other Applications
  - Germany Point-Of-Care Molecular Diagnostics, by Test
    - OTC
    - POC
  - Germany Point-Of-Care Molecular Diagnostics, by Technology
    - PCR-based
    - Genetic Sequencing-based
    - Hybridization-based
    - Microarray-based
  - Germany Point-Of-Care Molecular Diagnostics, by End Use
    - Decentralized Labs
    - Hospitals
    - Home-care
    - Assisted Living Healthcare Facilities
    - Other uses
- France
  - France Point-Of-Care Molecular Diagnostics, by Application
    - Infectious Diseases
      - HIV POC
      - Clostridium difficile POC
      - HBV POC
      - Pneumonia or Streptococcus associated infections
      - Respiratory syncytial virus (RSV) POC
      - HPV POC
      - Influenza/Flu POC
      - HCV POC
      - MRSA POC
      - TB and drug-resistant TB POC
      - HSV POC
      - Other Infectious Diseases
    - Oncology
    - Hematology
      - Complete blood count (CBC)
      - Prothrombin time (PT)
      - Partial Thromboplastin Time (PTT)
      - Others
    - Prenatal Testing
    - Endocrinology
    - Other Applications
  - France Point-Of-Care Molecular Diagnostics, by Test
    - OTC
    - POC
  - France Point-Of-Care Molecular Diagnostics, by Technology
    - PCR-based
    - Genetic Sequencing-based
    - Hybridization-based
    - Microarray-based
  - France Point-Of-Care Molecular Diagnostics, by End Use
    - Decentralized Labs
    - Hospitals
    - Home-care
    - Assisted Living Healthcare Facilities
    - Other uses
- Italy
  - Italy Point-Of-Care Molecular Diagnostics, by Application
    - Infectious Diseases
      - HIV POC
      - Clostridium difficile POC
      - HBV POC
      - Pneumonia or Streptococcus associated infections
      - Respiratory syncytial virus (RSV) POC
      - HPV POC
      - Influenza/Flu POC
      - HCV POC
      - MRSA POC
      - TB and drug-resistant TB POC
      - HSV POC
      - Other Infectious Diseases
    - Oncology
    - Hematology
      - Complete blood count (CBC)
      - Prothrombin time (PT)
      - Partial Thromboplastin Time (PTT)
      - Others
    - Prenatal Testing
    - Endocrinology
    - Other Applications
  - Italy Point-Of-Care Molecular Diagnostics, by Test
    - OTC
    - POC
  - Italy Point-Of-Care Molecular Diagnostics, by Technology
    - PCR-based
    - Genetic Sequencing-based
    - Hybridization-based
    - Microarray-based
  - Italy Point-Of-Care Molecular Diagnostics, by End Use
    - Decentralized Labs
    - Hospitals
    - Home-care
    - Assisted Living Healthcare Facilities
    - Other uses
- Spain
  - Spain Point-Of-Care Molecular Diagnostics, by Application
    - Infectious Diseases
      - HIV POC
      - Clostridium difficile POC
      - HBV POC
      - Pneumonia or Streptococcus associated infections
      - Respiratory syncytial virus (RSV) POC
      - HPV POC
      - Influenza/Flu POC
      - HCV POC
      - MRSA POC
      - TB and drug-resistant TB POC
      - HSV POC
      - Other Infectious Diseases
    - Oncology
    - Hematology
      - Complete blood count (CBC)
      - Prothrombin time (PT)
      - Partial Thromboplastin Time (PTT)
      - Others
    - Prenatal Testing
    - Endocrinology
    - Other Applications
  - Spain Point-Of-Care Molecular Diagnostics, by Test
    - OTC
    - POC
  - Spain Point-Of-Care Molecular Diagnostics, by Technology
    - PCR-based
    - Genetic Sequencing-based
    - Hybridization-based
    - Microarray-based
  - Spain Point-Of-Care Molecular Diagnostics, by End Use
    - Decentralized Labs
    - Hospitals
    - Home-care
    - Assisted Living Healthcare Facilities
    - Other uses
- Denmark
  - Denmark Point-Of-Care Molecular Diagnostics, by Application
    - Infectious Diseases
      - HIV POC
      - Clostridium difficile POC
      - HBV POC
      - Pneumonia or Streptococcus associated infections
      - Respiratory syncytial virus (RSV) POC
      - HPV POC
      - Influenza/Flu POC
      - HCV POC
      - MRSA POC
      - TB and drug-resistant TB POC
      - HSV POC
      - Other Infectious Diseases
    - Oncology
    - Hematology
      - Complete blood count (CBC)
      - Prothrombin time (PT)
      - Partial Thromboplastin Time (PTT)
      - Others
    - Prenatal Testing
    - Endocrinology
    - Other Applications
  - Denmark Point-Of-Care Molecular Diagnostics, by Test
    - OTC
    - POC
  - Denmark Point-Of-Care Molecular Diagnostics, by Technology
    - PCR-based
    - Genetic Sequencing-based
    - Hybridization-based
    - Microarray-based
  - Denmark Point-Of-Care Molecular Diagnostics, by End Use
    - Decentralized Labs
    - Hospitals
    - Home-care
    - Assisted Living Healthcare Facilities
    - Other uses
- Sweden
  - Sweden Point-Of-Care Molecular Diagnostics, by Application
    - Infectious Diseases
      - HIV POC
      - Clostridium difficile POC
      - HBV POC
      - Pneumonia or Streptococcus associated infections
      - Respiratory syncytial virus (RSV) POC
      - HPV POC
      - Influenza/Flu POC
      - HCV POC
      - MRSA POC
      - TB and drug-resistant TB POC
      - HSV POC
      - Other Infectious Diseases
    - Oncology
    - Hematology
      - Complete blood count (CBC)
      - Prothrombin time (PT)
      - Partial Thromboplastin Time (PTT)
      - Others
    - Prenatal Testing
    - Endocrinology
    - Other Applications
  - Sweden Point-Of-Care Molecular Diagnostics, by Test
    - OTC
    - POC
  - Sweden Point-Of-Care Molecular Diagnostics, by Technology
    - PCR-based
    - Genetic Sequencing-based
    - Hybridization-based
    - Microarray-based
  - Sweden Point-Of-Care Molecular Diagnostics, by End Use
    - Decentralized Labs
    - Hospitals
    - Home-care
    - Assisted Living Healthcare Facilities
    - Other uses
- Norway
  - Norway Point-Of-Care Molecular Diagnostics, by Application
    - Infectious Diseases
      - HIV POC
      - Clostridium difficile POC
      - HBV POC
      - Pneumonia or Streptococcus associated infections
      - Respiratory syncytial virus (RSV) POC
      - HPV POC
      - Influenza/Flu POC
      - HCV POC
      - MRSA POC
      - TB and drug-resistant TB POC
      - HSV POC
      - Other Infectious Diseases
    - Oncology
    - Hematology
      - Complete blood count (CBC)
      - Prothrombin time (PT)
      - Partial Thromboplastin Time (PTT)
      - Others
    - Prenatal Testing
    - Endocrinology
    - Other Applications
  - Norway Point-Of-Care Molecular Diagnostics, by Test
    - OTC
    - POC
  - Norway Point-Of-Care Molecular Diagnostics, by Technology
    - PCR-based
    - Genetic Sequencing-based
    - Hybridization-based
    - Microarray-based
  - Norway Point-Of-Care Molecular Diagnostics, by End Use
    - Decentralized Labs
    - Hospitals
    - Home-care
    - Assisted Living Healthcare Facilities
    - Other uses
- Russia
  - Russia Point-Of-Care Molecular Diagnostics, by Application
    - Infectious Diseases
      - HIV POC
      - Clostridium difficile POC
      - HBV POC
      - Pneumonia or Streptococcus associated infections
      - Respiratory syncytial virus (RSV) POC
      - HPV POC
      - Influenza/Flu POC
      - HCV POC
      - MRSA POC
      - TB and drug-resistant TB POC
      - HSV POC
      - Other Infectious Diseases
    - Oncology
    - Hematology
      - Complete blood count (CBC)
      - Prothrombin time (PT)
      - Partial Thromboplastin Time (PTT)
      - Others
    - Prenatal Testing
    - Endocrinology
    - Other Applications
  - Russia Point-Of-Care Molecular Diagnostics, by Test
    - OTC
    - POC
  - Russia Point-Of-Care Molecular Diagnostics, by Technology
    - PCR-based
    - Genetic Sequencing-based
    - Hybridization-based
    - Microarray-based
  - Russia Point-Of-Care Molecular Diagnostics, by End Use
    - Decentralized Labs
    - Hospitals
    - Home-care
    - Assisted Living Healthcare Facilities
    - Other uses
- Netherlands
  - Netherlands Point-Of-Care Molecular Diagnostics, by Application
    - Infectious Diseases
      - HIV POC
      - Clostridium difficile POC
      - HBV POC
      - Pneumonia or Streptococcus associated infections
      - Respiratory syncytial virus (RSV) POC
      - HPV POC
      - Influenza/Flu POC
      - HCV POC
      - MRSA POC
      - TB and drug-resistant TB POC
      - HSV POC
      - Other Infectious Diseases
    - Oncology
    - Hematology
      - Complete blood count (CBC)
      - Prothrombin time (PT)
      - Partial Thromboplastin Time (PTT)
      - Others
    - Prenatal Testing
    - Endocrinology
    - Other Applications
  - Netherlands Point-Of-Care Molecular Diagnostics, by Test
    - OTC
    - POC
  - Netherlands Point-Of-Care Molecular Diagnostics, by Technology
    - PCR-based
    - Genetic Sequencing-based
    - Hybridization-based
    - Microarray-based
  - Netherlands Point-Of-Care Molecular Diagnostics, by End Use
    - Decentralized Labs
    - Hospitals
    - Home-care
    - Assisted Living Healthcare Facilities
    - Other uses

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments